XBIT - XBiotech Inc.
2.34
0.010 0.427%
Share volume: 25,217
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.33
0.01
0.00%
Summary score
5%
Profitability
0%
Dept financing
1%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.08%
Return on assets
-10.48%
Return on sales
-43.15%
Return on invested capital
-26.4%
Total debt ratio
5.28%
Debt ratio change over timeo
0%
Current Ratio
13.39%
Quick Ratio
0%
Cash Position Ratio
13.09%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.36%
Return on assets
-1.57%
Return on sales
-43.15%
Return on invested capital
-5.18%
Total debt ratio
3.14%
Debt ratio change over timeo
0%
Current Ratio
29.31%
Quick Ratio
0%
Cash Position Ratio
27.36%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-0.73%
Return on assets
-1.32%
Return on sales
-44.27%
Return on invested capital
-2.63%
Total debt ratio
2.05%
Debt ratio change over time
0%
Current Ratio
40.5%
Quick Ratio
0%
Cash Position Ratio
38.47%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XBIT | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -11.08% | 18.71% | 4.67% | -3.65% |
| Return on assets | -10.48% | 3.4% | 3.32% | 3.5% |
| Return on sales | -43.15% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | -26.4% | 5.38% | 4.17% | 4.99% |
| Profitability | 0% | 94% | 70% | 73% |
| Total debt ratio | 5.28% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 1% | 20% | 20% | 50% |
| Current Ratio | 29.31% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 27.36% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 23% | 28% | 29% |
| Short-term ratios | XBIT | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -1.36% | 41.05% | 6.87% | -16.17% |
| Return on assets | -1.57% | 3.67% | 3.13% | 2.71% |
| Return on sales | -43.15% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | -5.18% | 9.43% | 5.58% | 6.54% |
| Profitability | 0% | 97% | 61% | 61% |
| Total debt ratio | 3.14% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 1% | 23% | 40% | 25% |
| Current Ratio | 29.31% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 27.36% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 14% | 16% | 28% |